Botanical species · safety record

Hedera helix

The EFSA Compendium of Botanicals holds 7 constituent measurements and 1 adverse-effect record for Hedera helix. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Hedera helix L.

7Constituent measurements
1Safety records
6Cited sources
87Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 87 licensed products naming Hedera helix as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry

Source material stated

  • Flowering twigs
  • Fresh, fully developed, non-lignified shootscollected before or at the beginning of the flowering period
  • Hedera helix
  • Herb flowering
  • Leaf
  • Leaf extract
  • Rameau en fleur
  • Shoots

What the records describe

Constituents measured

  • Triterpene saponins3
  • Saponins2
  • Beta-hederin1
  • Calcium oxalate1

Plant parts

  • Leaves3
  • Aerial part of plants2
  • Live plants1
  • Stem1
  • Unspecified1
  • stalk1

Preparations

  • Solvent extraction4

Target tissues

  • Digestive1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Beta-hederinStem / stalkChromatography hyphenated to element spectrometryResolve DOI
SaponinsLeavesSolvent extractionUnspecifiedResolve DOI
SaponinsLive plantsSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Triterpene saponinsLeavesSolvent extraction15.69 PercentHPLC-DADResolve DOI
Triterpene saponinsLeavesSolvent extraction1.05 PercentHPLC-DADResolve DOI
Triterpene saponinsAerial part of plantsResolve DOI
Calcium oxalateAerial part of plantsUnspecifiedNo resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
Not statedDigestiveUnspecifiedCase reportResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Busser, C. Toxic berries, fruits and pseudo-fruits in traditional medicine and phytotherapy . Phytotherapie (paris), 2007, vol. 5, no. 1, p. 31-36. DOI
  2. Yu, Miao., Shin, Young June., Kim, Nanyoung., Yoo, Guijae., Park, SeonJu., Kim, Seung Hyun. Determination of Saponins and Flavonoids in Ivy Leaf Extracts Using HPLC-DAD . Journal of chromatographic science, 2015, vol. 53, no. 4, p. 478-483. DOI
  3. Himmelsbach, Markus., Weth, Agnes., Boehme, Christine., Schwarz, Martin., Braeunig, Peter., Baumgartner, Werner. The plant hopper Issus coleoptratus can detoxify phloem sap saponins including the degradation of the terpene core . Biology open, 2016, vol. 5, no. 3, p. 252-255. DOI
  4. Tutuncu Konyar, Sevil., Ozturk, Necla., Dane, Feruzan. Occurrence, types and distribution of calcium oxalate crystals in leaves and stems of some species of poisonous plants. Botanical studies, 2014, vol. 55, no. 1, p. 1-9.
  5. ELIAS, R., DEMEO, M., VIDALOLLIVIER, E., LAGET, M., BALANSARD, G., DUMENIL, G. ANTIMUTAGENIC ACTIVITY OF SOME SAPONINS ISOLATED FROM CALENDULA-OFFICINALIS L, CALENDULA-ARVENSIS L AND HEDERA-HELIX L . Mutagenesis, 1990, vol. 5, no. 4, p. 327-331. DOI
  6. Walthelm, U., Dittrich, K., Gelbrich, G., Schopke, T. Effects of saponins on the water solubility of different model compounds. Planta medica, 2001, vol. 67, no. 1, p. 49-54. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue